Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer

International patterns and trends in ovarian cancer incidence, overall and by histologic subtype

(2017) S.B. Coburn et al.   INTERNATIONAL JOURNAL OF CANCER

A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells

(2017) Weisha Liu et al.   Molecular BioSystems

Rnf2 knockdown reduces cell viability and promotes cell cycle arrest in gastric cancer cells

(2017) Jingfang Zhang et al.   Oncology Letters

KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells

(2016) Hong Chen et al.   Cancer Cell International

miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53

(2016) Lin Wang et al.   ONCOLOGY REPORTS

miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1

(2016) Heyong Liu et al.   PATHOLOGY RESEARCH AND PRACTICE

miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52

(2016) Hong Chen et al.   OncoTargets and Therapy

miR-139-5p inhibits epithelial–mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2

(2015) Gongcai Qiu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Placental Growth Factor Promotes Metastases of Ovarian Cancer Through MiR-543-Regulated MMP7

(2015) Ning Song et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

MicroRNAs as Regulators of Cisplatin Resistance in Lung Cancer

(2015) Ying Chen et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Dual Roles of RNF2 in Melanoma Progression

(2015) K. Rai et al.   Cancer Discovery

Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin-resistant ovarian cancer

(2014) YA XIE et al.   Molecular Medicine Reports

Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma

(2014) HENAN ZHAO et al.   ONCOLOGY REPORTS

miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation

(2014) C Denoyelle et al.   Cell Death & Disease

Effect of the LPA-mediated CXCL12-CXCR4 axis in the tumor proliferation, migration and invasion of ovarian cancer cell lines

(2014) HUI WANG et al.   Oncology Letters

MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1

(2014) Mingxu Song et al.   Protein & Cell

New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential

(2013) S. Banerjee et al.   CLINICAL CANCER RESEARCH

RNF2/Ring1b negatively regulates p53 expression in selective cancer cell types to promote tumor development

(2013) W.-j. Su et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

miR-21 modulates paclitaxel sensitivity and hypoxia-inducible factor-1α expression in human ovarian cancer cells

(2013) ZHONGBIN XIE et al.   Oncology Letters

KLF15 negatively regulates estrogen-induced epithelial cell proliferation by inhibition of DNA replication licensing

(2012) S. Ray et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo

(2012) WEI LI et al.   Oncology Letters

Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer

(2011) Callinice D Capo-chichi et al.   BMC Medicine

Subamolide A, a component isolated from Cinnamomum subavenium, induces apoptosis mediated by mitochondria-dependent, p53 and ERK1/2 pathways in human urothelial carcinoma cell line NTUB1

(2011) Chiung-Hui Liu et al.   JOURNAL OF ETHNOPHARMACOLOGY

miR-495 is upregulated by E12/E47 in breast cancer stem cells and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1

(2011) W W Hwang-Verslues et al.   ONCOGENE

Specific Thiazolidinediones Inhibit Ovarian Cancer Cell Line Proliferation and Cause Cell Cycle Arrest in a PPARγ Independent Manner

(2011) Linah Al-Alem et al.   PLoS One

Curcumin synergizes with resveratrol to stimulate the MAPK signaling pathway in human articular chondrocytes in vitro

(2010) Mehdi Shakibaei et al.   Genes and Nutrition

Cisplatin-Induced DNA Damage Activates Replication Checkpoint Signaling Components that Differentially Affect Tumor Cell Survival

(2009) J. M. Wagner et al.   MOLECULAR PHARMACOLOGY

RNF2 is the target for phosphorylation by the p38 MAPK and ERK signaling pathways

(2009) Prema S. Rao et al.   PROTEOMICS